AAAAAA

   
Results: 1-18 |
Results: 18
SALVAGE CHEMOTHERAPY OF METASTATIC BREAST-CANCER WITH DOCETAXEL AND GEMCITABINE - A MULTICENTER PHASE-II TRIAL
Authors: MAVROUDIS D MALAMOS N GIANNAKAKIS T ALEXOPOULOS A POTAMIANOU A RIGATOS G KOSMAS C SARRA E PAPADOURIS S GEORGOULIAS V
Citation: D. Mavroudis et al., SALVAGE CHEMOTHERAPY OF METASTATIC BREAST-CANCER WITH DOCETAXEL AND GEMCITABINE - A MULTICENTER PHASE-II TRIAL, Annals of oncology, 9, 1998, pp. 90-90
PHASE-I STUDY OF DOCETAXEL AND EPIRUBICIN IN ADVANCED BREAST-CANCER
Authors: PANAGOS G MAVROUDIS D POTAMIANOU A MALAMOS N KOUROUSIS C KAKOLYRIS S SOUGLAKOS J SARRA E GIANNAKAKIS T GEORGOULIAS V
Citation: G. Panagos et al., PHASE-I STUDY OF DOCETAXEL AND EPIRUBICIN IN ADVANCED BREAST-CANCER, Annals of oncology, 9, 1998, pp. 97-97
TREATMENT OF METASTATIC BREAST-CANCER WITH INTENSIFIED COMBINATION OFDOCETAXEL AND MITOXANTRONE - A MULTICENTER PHASE-II TRIAL
Authors: ALEXOPOULOS A MALAMOS N GIANNAKAKIS T MAUROUDIS D PANAGOS G AGELAKI S KOSMAS C SOUGLAKOS J VARDAKIS N APOSTOLAKI F GEORGOULIAS V
Citation: A. Alexopoulos et al., TREATMENT OF METASTATIC BREAST-CANCER WITH INTENSIFIED COMBINATION OFDOCETAXEL AND MITOXANTRONE - A MULTICENTER PHASE-II TRIAL, Annals of oncology, 9, 1998, pp. 127-127
PHASE I II TRIAL OF DOCETAXEL (D) AND CARBOPLATIN (CBDCA) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)/
Authors: GIANNAKAKIS T PAPADOURIS S KOUROUSIS C KALBAKIS NK TZIANNI V LIDAKI E ANDROULAKIS N SOUKLAKOS J SARRA E GEORGOULIAS V
Citation: T. Giannakakis et al., PHASE I II TRIAL OF DOCETAXEL (D) AND CARBOPLATIN (CBDCA) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 452-452
TROPISETRON IN THE PREVENTION OF ACUTE NAUSEA AND VOMITING IN PATIENTS TREATED WITH HIGH-DOSE EPIRUBICIN
Authors: NICOLAIDES C GIANNAKAKIS T SKARLOS D ATHANASSIADIS A FOUNTZILAS G DAMIGOS D PAVLIDIS N
Citation: C. Nicolaides et al., TROPISETRON IN THE PREVENTION OF ACUTE NAUSEA AND VOMITING IN PATIENTS TREATED WITH HIGH-DOSE EPIRUBICIN, Journal of experimental & clinical cancer research, 17(1), 1998, pp. 71-75
DIFFUSE LARGE-CELL LYMPHOMAS - IDENTIFICATION OF PROGNOSTIC FACTORS AND VALIDATION OF THE INTERNATIONAL NON-HODGKINS-LYMPHOMA PROGNOSTIC INDEX - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: NICOLAIDES C FOUNTZILAS G ZOUMBOS N SKARLOS D KOSMIDIS P PECTASIDES D KARABELIS A GIANNAKAKIS T SYMEONIDIS A PAPADOPOULOS A ANTONIOU F PAVLIDIS N
Citation: C. Nicolaides et al., DIFFUSE LARGE-CELL LYMPHOMAS - IDENTIFICATION OF PROGNOSTIC FACTORS AND VALIDATION OF THE INTERNATIONAL NON-HODGKINS-LYMPHOMA PROGNOSTIC INDEX - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Oncology, 55(5), 1998, pp. 405-415
A PHASE-II STUDY OF PACLITAXEL IN PLATINUM PRETREATED OVARIAN-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: ARAVANTINOS G SKARLOS DV KOSMIDIS P ATHANASSIADES A BAFALOUKOS D GIANNAKAKIS T KARPATHIOS S FOUNTZILAS G
Citation: G. Aravantinos et al., A PHASE-II STUDY OF PACLITAXEL IN PLATINUM PRETREATED OVARIAN-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, European journal of cancer, 33(1), 1997, pp. 160-163
A RANDOMIZED STUDY OF EPIRUBICIN MONOTHERAPY EVERY 4 OR EVERY 2 WEEKSIN ADVANCED BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: FOUNTZILAS G ATHANASSIADES A GIANNAKAKIS T BRIASOULIS E BAFALOUKOS D KALOGERAFOUNTZILA A ONIENAOUM A KALOFONOS H PECTASIDES D ANDREOPOULOU E BAMIA C KOSMIDIS P PAVLIDIS N SKARLOS D
Citation: G. Fountzilas et al., A RANDOMIZED STUDY OF EPIRUBICIN MONOTHERAPY EVERY 4 OR EVERY 2 WEEKSIN ADVANCED BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Annals of oncology, 8(12), 1997, pp. 1213-1220
CHEMOTHERAPY WITH METHOTREXATE, VINBLASTINE, EPIRUBICIN AND CARBOPLATIN (CARBO-MVE) IN TRANSITIONAL-CELL UROTHELIAL CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: SKARLOS DV ARAVANTINOS G LINARDOU E KOSTAKOPOULOS CA KASTRIOTIS I CHRISTODOULOU C PICRAMENOS D GIANNAKAKIS T DIMOPOULOS K FOUNTZILAS G
Citation: Dv. Skarlos et al., CHEMOTHERAPY WITH METHOTREXATE, VINBLASTINE, EPIRUBICIN AND CARBOPLATIN (CARBO-MVE) IN TRANSITIONAL-CELL UROTHELIAL CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, European urology, 31(4), 1997, pp. 420-427
A PHASE-II STUDY OF PACLITAXEL IN ADVANCED BREAST-CANCER RESISTANT TOANTHRACYCLINES
Authors: FOUNTZILAS G ATHANASSIADES A GIANNAKAKIS T BAFALOUKOS D KARAKOUSIS K DOMBROS N KOSMIDIS P SKARLOS D
Citation: G. Fountzilas et al., A PHASE-II STUDY OF PACLITAXEL IN ADVANCED BREAST-CANCER RESISTANT TOANTHRACYCLINES, European journal of cancer, 32A(1), 1996, pp. 47-51
RECOMBINANT INTERFERON ALFA-2A IN COMBINATION WITH CARBOPLATIN, VINBLASTINE, AND BLEOMYCIN IN THE TREATMENT OF ADVANCED MALIGNANT-MELANOMA
Authors: BAFALOUKOS D PAVLIDIS N FOUNTZILAS G SKARLOS D KLOUVAS G MAKRANTONAKIS P GIANNAKAKIS T TSAVARIS N KOSMIDIS P
Citation: D. Bafaloukos et al., RECOMBINANT INTERFERON ALFA-2A IN COMBINATION WITH CARBOPLATIN, VINBLASTINE, AND BLEOMYCIN IN THE TREATMENT OF ADVANCED MALIGNANT-MELANOMA, American journal of clinical oncology, 19(3), 1996, pp. 296-300
CYCLOPHOSPHAMIDE, MITOXANTRONE, FLUOROURACIL VERSUS CONVENTIONAL CMF AS ADJUVANT TREATMENT IN NODE-POSITIVE BREAST-CANCER PATIENTS - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: FOUNTZILAS G KATSOHIS K TOUSSIS D KOSMIDIS P SEMOGLOU C FAHANTIDIS E TSAVARIS N MAKRANTONAKIS P ZAMBOGLOU N HAINOGLOU D PAVLIDIS N POLICHRONIS A GENNATAS K SKARLOS D VASSILAROS S GIANNAKAKIS T KLOUVAS G KONSTANTARAS C KOLOTAS C TSILIAKOS S MYLONAKIS N
Citation: G. Fountzilas et al., CYCLOPHOSPHAMIDE, MITOXANTRONE, FLUOROURACIL VERSUS CONVENTIONAL CMF AS ADJUVANT TREATMENT IN NODE-POSITIVE BREAST-CANCER PATIENTS - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Oncology, 53(2), 1996, pp. 137-146
PHASE-II STUDY OF 5-FLUOROURACIL AND INTERFERON-GAMMA IN PATIENTS WITH METASTATIC COLORECTAL-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: PAVLIDIS N NICOLAIDES C ATHANASSIADIS A BERIATOU K SKARLOS D GIANNAKAKIS T KOSMIDIS P KARVOUNIS N FOUNTZILAS G
Citation: N. Pavlidis et al., PHASE-II STUDY OF 5-FLUOROURACIL AND INTERFERON-GAMMA IN PATIENTS WITH METASTATIC COLORECTAL-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Oncology, 53(2), 1996, pp. 159-162
INTENSIFIED ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH BREAST-CANCER ANDLESS-THAN-10 POSITIVE LYMPH-NODES - A PHASE-II STUDY
Authors: FOUNTZILAS G SKARLOS D ATHANASSIADIS A NIKOLAIDES C GIANNAKAKIS T BAFALOUKOS D PAPAKOSTAS P STATHOPOULOS G KOSMIDIS P PAVLIDIS N
Citation: G. Fountzilas et al., INTENSIFIED ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH BREAST-CANCER ANDLESS-THAN-10 POSITIVE LYMPH-NODES - A PHASE-II STUDY, European journal of cancer, 31A, 1995, pp. 69-69
A RANDOMIZED STUDY COMPARING ONDANSETRON (OND) WITH ONDANSETRON PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC) RECEIVING HIGH-DOSE EPIRUBICIN (HDE) - PRELIMINARY-REPORT
Authors: GIANNAKAKIS T SKARLOS D ATHANASIADES A FOUNTZILAS G BAFALOUKOS D KOSMIDIS P NIKOLAIDES K PAVLIDIS N
Citation: T. Giannakakis et al., A RANDOMIZED STUDY COMPARING ONDANSETRON (OND) WITH ONDANSETRON PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC) RECEIVING HIGH-DOSE EPIRUBICIN (HDE) - PRELIMINARY-REPORT, European journal of cancer, 31A, 1995, pp. 1235-1235
HIGH-DOSE EPIRUBICIN AND R-MET-HU G-CSF (FILGRASTIM) IN THE TREATMENTOF PATIENTS WITH ADVANCED BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: FOUNTZILAS G SKARLOS D KATSOHIS C PAVLIDIS N GIANNAKAKIS T BAFALOUKOS D FAHANTIDIS E KLOUVAS G BEER M KOSMIDIS P
Citation: G. Fountzilas et al., HIGH-DOSE EPIRUBICIN AND R-MET-HU G-CSF (FILGRASTIM) IN THE TREATMENTOF PATIENTS WITH ADVANCED BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Medical and pediatric oncology, 24(1), 1995, pp. 23-28
INTENSIVE CHEMOTHERAPY WITH HIGH-DOSE EPIRUBICIN EVERY 2 WEEKS AND PROPHYLACTIC ADMINISTRATION OF FILGRASTIM IN ADVANCED BREAST-CANCER
Authors: FOUNTZILAS G SKARLOS D GIANNAKAKIS T ATHANASIADES A BAFALOUKOS D KALOGERAFOUNTZILA A BAMIA C PAVLIDIS N KOSMIDIS P
Citation: G. Fountzilas et al., INTENSIVE CHEMOTHERAPY WITH HIGH-DOSE EPIRUBICIN EVERY 2 WEEKS AND PROPHYLACTIC ADMINISTRATION OF FILGRASTIM IN ADVANCED BREAST-CANCER, European journal of cancer, 30A(7), 1994, pp. 965-969
CARBOPLATIN AND ORAL ETOPOSIDE IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CANCER REFRACTORY TO ANTHRACYCLINES
Authors: FOUNTZILAS G SKARLOS D THEOHARIS D GIANNAKAKIS T STATHOPOULOS G
Citation: G. Fountzilas et al., CARBOPLATIN AND ORAL ETOPOSIDE IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CANCER REFRACTORY TO ANTHRACYCLINES, Tumori, 79(6), 1993, pp. 389-392
Risultati: 1-18 |